獸藥市場規模、佔有率和成長分析：按產品類型、動物種類、劑型、給藥途徑、配銷通路和地區分類－2026-2033年產業預測

2024 年全球動物藥品市場價值為 18.5 億美元，預計到 2025 年將成長至 20.1 億美元，到 2033 年將成長至 39.2 億美元，在預測期（2026-2033 年）內複合年成長率為 8.7%。

全球動物藥品市場正經歷強勁成長，這主要得益於對個性化獸醫護理需求的不斷成長，而寵物數量的增加以及針對伴侶動物和異寵的專用治療方法的日益普及，進一步推動了這一成長。獸醫藥品服務的創新以及對動物福利的高度重視，也進一步促進了這一趨勢。對客製化口服液、調味藥物、外用凝膠、無菌注射劑和個人化製劑的需求預計將推動市場擴張。對現代化配藥實驗室、遠距藥事照護解決方案和品管系統的投資，在提高醫療品質的同時，也緩解了產品短缺的問題。然而，嚴格的監管合規性、一致性問題、無菌配藥的高昂營運成本以及缺乏標準化指南等挑戰，可能會阻礙市場滲透。

全球動物藥品市場按產品類型、動物種類、劑型、給藥途徑、通路及地區細分。依產品類型分類，可分為抗感染藥、抗發炎藥物、荷爾蒙及其替代品、中樞神經系統藥物、消化器官系統藥物和其他藥物。依動物種類分類，可分為伴侶動物及家畜。依劑型分類，可分為膠囊、粉末、溶液、懸浮液和軟膏/乳霜。依給藥途徑分類，可分為口服、注射、外用、眼藥水和直腸給藥。依分銷管道分類，可分為獸醫院、獸醫診所、藥局和線上獸藥店。依地區分類，市場分為北美、歐洲、亞太、拉丁美洲以及中東和非洲。

推動全球動物藥品市場發展的因素

全球動物藥品市場的主要促進因素之一是人們對個人化獸醫學的日益關注。隨著寵物飼主越來越傾向於為愛寵量身定做治療方法，獸醫也被鼓勵開立針對特定寵物健康需求的定製藥物。配製技術的進步和法規結構的完善進一步推動了這一趨勢，促進了定製藥物的製備。此外，寵物慢性病發病率的上升和寵物數量的快速成長也增加了對專業配製藥物的需求，從而推動了該領域的市場成長。

全球動物藥品市場的限制因素

全球動物藥品市場的主要限制因素之一是圍繞這些藥物的嚴格法規結構。監管機構制定了嚴格的指導方針以確保藥物的安全性、有效性和質量，這可能會阻礙藥局的產品開發速度和市場准入。包括良好生產規範 (GMP) 在內的各項標準的合規要求會增加營運成本，並限制中小企業的競爭力。此外，對獸藥使用日益嚴格的審查可能會導致獸醫和​​寵物飼主對藥物的接受度和信任度下降，進一步限制市場成長。

全球動物藥品市場趨勢

全球動物藥品市場正呈現出向精準醫療發展的顯著趨勢，這主要得益於對針對特定物種定製配方藥物的日益成長的需求。這種對個人化醫療的需求使得劑量和給藥方式柔軟性，進而改善治療效果並提升顧客滿意度。隨著獸醫尋求針對市售藥物無法有效治療的疾病的解決方案，配製藥物的需求日益成長，尤其是在治療寵物慢性疾病和行為問題方面。這種對個人化治療的關注凸顯了配製服務在不斷發展的獸醫學領域的重要性，並確立了其作為動物醫療保健重要組成部分的地位。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢
• 價值鏈分析
• 案例研究
• 技術評估
• 客戶和採購標準分析
• 管道分析
• 疾病流行病學

全球動物藥品市場規模：依產品類別分類

• 抗感染劑
• 抗發炎藥
• 荷爾蒙及其替代品
• 中樞神經系統藥物
• 消化器官系統藥物
• 其他

全球動物藥品市場規模：依動物類型分類

• 伴侶動物
• 家畜

全球動物藥品市場規模：以劑型分類

• 膠囊
• 粉末
• 解決方案
• 暫停
• 藥膏和乳霜

全球動物藥品市場規模：依給藥途徑分類

• 口服
• 注射藥物
• 外用
• 眼科
• 直腸

全球動物藥品市場規模：依通路分類

• 動物醫院
• 動物診所
• 藥局
• 在線獸藥房

全球動物藥品市場規模：依地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Wedgewood Pharmacy
• Vimian Group AB
• MEDISCA Inc.
• Triangle Compounding Pharmacy
• Pace Pharmacy
• Aurora Compounding
• Miller's Pharmacy
• Vertisis Custom Pharmacy
• Chiron Compounding Pharmacy
• Akina Animal Health
• Chewy, Inc.
• Covetrus, Inc.
• PetMeds
• Mixlab, Inc.
• People's Choice Pharmacy
• Smith Caldwell Drug Store
• Dougherty's Pharmacy
• Pratt's Compounding Pharmacy
• Hoye's Pharmacy
• Victoria Compounding Pharmacy

結論與建議

Global Animal Drug Compounding Market size was valued at USD 1.85 Billion in 2024 and is poised to grow from USD 2.01 Billion in 2025 to USD 3.92 Billion by 2033, growing at a CAGR of 8.7% during the forecast period (2026-2033).

The global animal drug compounding market is experiencing robust growth due to heightened demand for personalized veterinary therapies, fueled by rising pet ownership and the adoption of specialized treatments for both companion and exotic animals. Innovations in veterinary pharmacy services and a strong emphasis on animal welfare are further propelling this trend. The need for customized oral liquids, flavored medications, topical gels, sterile injectables, and tailored dosage forms is expected to drive market expansion. Investments in modern compounding labs, telepharmacy solutions, and quality management systems are enhancing care quality while addressing product shortages. However, challenges such as stringent regulatory compliance, consistency concerns, high operational costs of sterile compounding, and a lack of standardized guidelines may hinder market penetration opportunities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Animal Drug Compounding market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Animal Drug Compounding Market Segments Analysis

Global animal drug compounding market is segmented by product, animal type, dosage form, route of administration, distribution channel,and region. Based on product, the market is segmented into anti-infective agents, anti-inflammatory agents, hormones & substitutes, CNSagents, GI drugs,and others. Based on animal type, the market is segmented into companion animals and livestock animals. Based on dosage form, the market is segmented into capsules, powders, solutions, suspensions,and ointments & creams. Based on route of administration, the market is segmented into oral, injectable, topical, ocular,and rectal. Based on distribution channel, the market is segmented into veterinary hospitals, veterinary clinics, compounding pharmacies,and online veterinary pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America,and Middle East & Africa.

Driver of the Global Animal Drug Compounding Market

One key market driver for the Global Animal Drug Compounding Market is the growing emphasis on personalized veterinary medicine. As pet owners increasingly seek tailored treatment solutions for their animals, veterinarians are prompted to prescribe customized medications that address the specific health needs of individual pets. This trend is further supported by advancements in compounding technology and regulatory frameworks that facilitate the preparation of bespoke pharmaceuticals. Additionally, the rising incidence of chronic health conditions in pets and the surge in pet ownership contribute to the demand for specialized compounded medications, driving market growth in this sector.

Restraints in the Global Animal Drug Compounding Market

One of the key market restraints for the global animal drug compounding market is the stringent regulatory framework surrounding compounded medications. Regulatory agencies impose rigorous guidelines to ensure safety, efficacy, and quality, which can hinder the speed of product development and market entry for compounding pharmacies. The requirement for compliance with various standards, including Good Manufacturing Practices (GMP), can increase operational costs and limit the ability of smaller firms to compete effectively. Additionally, the growing scrutiny on the use of compounded drugs in veterinary medicine may lead to reduced acceptance and confidence among veterinarians and pet owners, further restricting market growth.

Market Trends of the Global Animal Drug Compounding Market

The Global Animal Drug Compounding market is experiencing a notable trend towards precision therapeutics, driven by the increasing reliance on customized formulations tailored to specific species. This demand for personalized medicine facilitates flexibility in dosing and administration, enhancing treatment effectiveness and ensuring higher customer satisfaction. As veterinarians seek solutions for conditions that lack adequate commercially available pharmaceuticals, the need for compounded medications becomes paramount, particularly in addressing chronic diseases and behavioral issues in pets. This emphasis on individualization in therapy underscores the significance of compounding services in the evolving landscape of veterinary medicine, positioning them as essential components of animal healthcare.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape
• Value Chain Analysis
• Case Studies
• Technology Assessment
• Customer & Buying Criteria Analysis
• Pipeline Analysis
• Disease Epidemiology

Global Animal Drug Compounding Market Size by Product & CAGR (2026-2033)

• Market Overview
• Anti-Infective Agents
• Anti-Inflammatory Agents
• Hormones & Substitutes
• CNS Agents
• GI Drugs
• Others

Global Animal Drug Compounding Market Size by Animal Type & CAGR (2026-2033)

• Market Overview
• Companion Animals
• Livestock Animals

Global Animal Drug Compounding Market Size by Dosage Form & CAGR (2026-2033)

• Market Overview
• Capsules
• Powders
• Solutions
• Suspensions
• Ointments & Creams

Global Animal Drug Compounding Market Size by Route of Administration & CAGR (2026-2033)

• Market Overview
• Oral
• Injectable
• Topical
• Ocular
• Rectal

Global Animal Drug Compounding Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Veterinary Hospitals
• Veterinary Clinics
• Compounding Pharmacies
• Online Veterinary Pharmacies

Global Animal Drug Compounding Market Size & CAGR (2026-2033)

• North America (Product, Animal Type, Dosage Form, Route of Administration, Distribution Channel)
  • US
  • Canada
• Europe (Product, Animal Type, Dosage Form, Route of Administration, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Animal Type, Dosage Form, Route of Administration, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Animal Type, Dosage Form, Route of Administration, Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Animal Type, Dosage Form, Route of Administration, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Wedgewood Pharmacy
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vimian Group AB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MEDISCA Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Triangle Compounding Pharmacy
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pace Pharmacy
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aurora Compounding
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miller's Pharmacy
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vertisis Custom Pharmacy
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chiron Compounding Pharmacy
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Akina Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chewy, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Covetrus, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PetMeds
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mixlab, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• People's Choice Pharmacy
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith Caldwell Drug Store
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dougherty's Pharmacy
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pratt's Compounding Pharmacy
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hoye's Pharmacy
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Victoria Compounding Pharmacy
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations